These varieties contain the steroid, diosgenin, which is a principal material used in the manufacture of a number of synthetic steroidal hormones, such as those used in hormonal contraception.
These include biomedical information systems and a number of new transdermal therapies, e.g. transdermal hormonal contraception (1988), including its first time clinical proof (together with L. Wildt, University of Erlangen).